Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy
2005
Nutraceuticals: Facts and fiction
2007 Standout
Chronic oxidative stress and radiation‐induced late normal tissue injury: a review
2004
Radical cystectomy for elderly patients with bladder carcinoma
1998
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
2003
Targeting of superoxide dismutase and catalase to vascular endothelium
2001
Antifibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts
2001
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Topical superoxide dismutase reduces post‐irradiation breast cancer fibrosis
2004
Head and neck cancer
2008 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The human keratins: biology and pathology
2008 Standout
The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway
2004
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and α-tocopherol: an experimental study
1999
Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury
2003
Intratracheal injection of adenovirus containing the human MNSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis
1999
Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.
1998
Conformity index: A review
2006 Standout
Successful treatment of radiation-induced fibrosis using and Mn-SOD: An experimental study
1996
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
2006
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies
2003
Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma
2005
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer
2004
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
2000
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Pathogenetic mechanisms in radiation fibrosis
2010
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration
2006
Pharmacologic Modification of Radiation-Induced Late Normal Tissue Injury
1998
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Cancer and Radiation Therapy: Current Advances and Future Directions
2012 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
Clinical utility of cytokeratins as tumor markers
2004
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury
2007
A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile Neutropenia
2001
A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury
2002
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Sod mimetics are coming of age
2002
High-dose reirradiation of head and neck cancer with curative intent
1994
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
Occult primary head and neck carcinoma
2007
Role of antioxidants in paraquat toxicity
2002 Standout
Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-β) receptor mediated by adenoviral vector
2004
Toxicity antagonists in head and neck cancer
1998
Modifying Normal Tissue Damage Postirradiation
2002
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis
2007
The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes
2001
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysis
2003 Standout
Strategies to improve radiotherapy with targeted drugs
2011
Mécanismes biologiques des effets tardifs des radiations ionisantes
1997
Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol.
1998
Head and Neck Cancer
2001 Standout
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy
2005
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Delivery of Antioxidant Enzyme Proteins to the Lung
2001
Kinetics of Response to Long-Term Treatment Combining Pentoxifylline and Tocopherol in Patients With Superficial Radiation-Induced Fibrosis
2005
In Vivo Radioprotective Effects of Angiogenic Growth Factors on the Small Bowel of C3H Mice
1998
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced Fibrosis
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Bladder Cancer
2020 Standout
Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
2014
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
2000
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium
2006
Cancer treatment and survivorship statistics, 2016
2016 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Resistance to methicillin and virulence ofStaphylococcus aureus strains in bacteriemic cancer patients
1993
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Proton-Coupled Electron Transfer
2012 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of C Maulard being referenced
Successful treatment of radiation-induced fibrosis using liposomal superoxide dismutase: clinical trial
1994
Phase I?II study of the somatostatin analogue lanreotide in hormone-refractory prostate cancer
1995
Split course interstitial brachytherapy with a source shift: The results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy ≥ 4 cm diameter in 23 patients
1992
Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.
1993
Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma
1992
Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study
1994
Traitement empirique des épisodes fébriles survenant chez les patients cancéreux présentant une neutropénie prolongée : essai comparatif ceftazidime seule, ceftazidime + amikacine et ceftazidime + vancomycine
1991